RecruitingPhase 2NCT07294118

Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage

Endovascular Infusion of Lidocaine and Steroids in the Middle Meningeal Artery for Pain Management in Spontaneous Subarachnoid Hemorrhage Patients

Sponsor

The University of Texas Medical Branch, Galveston

Enrollment

15 participants

Start Date

Jan 2, 2026

Study Type

INTERVENTIONAL

Conditions

Opioid Use Subarachnoid Hemorrhage, Aneurysmal Headache Opiate Dependence

Summary

The goal of this clinical trial is to learn if an infusion of lidocaine, with or without steroids, into the middle meningeal artery (MMA) helps relieve severe headaches in patients with spontaneous subarachnoid hemorrhage (SAH). It will also study the safety of this treatment.

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Lidocaine and a drug called Lidocaine and Dexamethasone for people with headache, opiate dependence, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLidocaine

The participants will receive 50 mg of lidocaine.

DRUGLidocaine and Dexamethasone

The participants will receive 50 mg of lidocaine and 10 mg of dexamethasone one after the other.

Locations(1)

University of Texas Medical Branch, Galveston

Galveston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07294118

Related Trials

Immediate Neuromuscular Responses of the Obliquus Capitis Inferior Following Upper Cervical Manual Therapy

NCT077251981 location

Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects

NCT069811951 location